Correlation Between Centessa Pharmaceuticals and Unity Biotechnology
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Unity Biotechnology, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Unity Biotechnology.
Diversification Opportunities for Centessa Pharmaceuticals and Unity Biotechnology
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Centessa and Unity is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Unity Biotechnology go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Unity Biotechnology
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.11 times more return on investment than Unity Biotechnology. However, Centessa Pharmaceuticals is 1.11 times more volatile than Unity Biotechnology. It trades about 0.11 of its potential returns per unit of risk. Unity Biotechnology is currently generating about -0.11 per unit of risk. If you would invest 1,588 in Centessa Pharmaceuticals PLC on September 3, 2024 and sell it today you would earn a total of 203.00 from holding Centessa Pharmaceuticals PLC or generate 12.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Unity Biotechnology
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Unity Biotechnology |
Centessa Pharmaceuticals and Unity Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Unity Biotechnology
The main advantage of trading using opposite Centessa Pharmaceuticals and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.The idea behind Centessa Pharmaceuticals PLC and Unity Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Unity Biotechnology vs. DiaMedica Therapeutics | Unity Biotechnology vs. Lyra Therapeutics | Unity Biotechnology vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |